The expression level of circulating EV-RNAs in two ALK-translocated lung adenocarcinoma patients at different stages of treatment (Figure 4A,B) were assayed (complete profile in Figure S2A,B). The gene discussed is ALK; the disease is lung adenocarcinoma.